Beyond Andrology: Trends in Men ’s Health in Emerging Markets

< div class= " field field-name-body field-type-text-with-summary field-label-hidden " > < div class= " field-items " > < div class= " field-item even " > < p > In my < a href= " http://social.eyeforpharma.com/column/opportunity-womens-health-emerging-markets " > last column < /a > , I explored the concept of women ’s health and considered the specific challenges that adversely impact female health outcomes in emerging markets as a result of their gendered roles in society. This month, I turn my attention to men’s health and look at how men in emerging markets face a different set of health challenges, a gain influenced in large part by the way gender is socially constructed, with the pressure to be a ‘macho’ man often having negative consequences on health.  < /p > < p > As with women ’s health, men’s health can have both broad and narrow definitions. The narrow definition begins with andrology; conditions specific to male biology – such as prostate problems, testicular cancer and erectile dysfunction. It is revealing to note that while androgyny’s female counterpart, gyn ecology, is a board-certified medical specialty in many countries, andrology is not. It has only been described as a distinct specialty since the late 1960s. This lack of recognition perhaps goes some way to explaining why conditions such as the andropause – the male menopause or ‘manopause’, in which testosterone levels diminish with age – remain controversial.  While recent res...

Source: EyeForPharma - June 30, 2016 Category: Pharmaceuticals Authors: Marc Yates Source Type: news